References

1. Di Renzo et al. (2017) Preterm labor and birth management: recommendations from the European association of perinatal medicine. Matern Fetal Neonatal Med. 17, 2011-30.  – Read here 
2.  Nikolova T., Bayev O., Nikolova N., Di Renzo G.C. (2015) Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor. J Perinat Med. 43, 395-402. – Read here
3. Grobman, W.A., Welshman, E.E., Calhoun, E.A. (2004) Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial. Am J Obstet Gynecol.191, 235-40. – Read here
4. Alfirevic, Z., Allen-Coward, H., Vinuesa, F. (2007) Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial. Ultrasound Obstet Gynecol. 29,47–50. – Read here
5. Melchor et al. (2018) Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study. Ultrasound Obstet Gynecol. doi: 10.1002/uog.18892. – Read here
6. YHEC, Economic Evaluation Case Study: PartoSure – Read here